Annovis Bio, Inc. (ANVS) Revenue History
Annual and quarterly revenue from 2017 to 2025
Compound Annual Growth Rate (CAGR)
Loading revenue history...
ANVS Revenue Growth
ANVS Revenue Analysis (2017–2025)
As of May 8, 2026, Annovis Bio, Inc. (ANVS) generated trailing twelve-month (TTM) revenue of $0. The most recent quarter (Q4 2025) recorded $0 in revenue.
Looking at the longer-term picture, ANVS's historical revenue data shows various trends over time.
When compared to Healthcare sector peers including PRTA (-58.0% YoY), and ACAD (+9.9% YoY). Compare ANVS vs PRTA →
ANVS Revenue vs Peers
Revenue metrics vs comparable public companies
| Company | TTM Revenue | YoY Growth | 5Y CAGR | Op. Margin | Compare |
|---|---|---|---|---|---|
| ANVSCurrent | $0 | - | - | - | |
 PRTA | $10M | -58.0% | +62.6% | -1905.8% | |
 ACAD | $1.1B | +9.9% | +19.4% | 9.8% |
ANVS Historical Revenue Data (2017–2025)
| Year | Revenue | YoY % | Gross Profit | Gross Margin | Op. Income | Op. Margin |
|---|---|---|---|---|---|---|
| 2025 | $0 | - | $0 | - | $-29,695,258 | - |
| 2024 | $0 | - | $0 | - | $-26,694,928 | - |
| 2023 | $0 | - | $0 | - | $-45,035,000 | - |
| 2022 | $0 | - | $0 | - | $-25,511,279 | - |
| 2021 | $0 | - | $0 | - | $-14,537,221 | - |
| 2020 | $0 | - | $0 | - | $-6,640,221 | - |
| 2019 | $0 | - | $0 | - | $-1,606,000 | - |
| 2018 | $0 | - | $0 | - | $-714,000 | - |
| 2017 | $0 | - | $0 | - | $-682,000 | - |
See ANVS's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs ANVS Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare ANVS vs DBVT
Side-by-side business, growth, and profitability comparison vs DBV Technologies S.A..
Start ComparisonANVS — Frequently Asked Questions
Quick answers to the most common questions about buying ANVS stock.
Is ANVS's revenue growth accelerating or slowing?
ANVS TTM revenue: $0.00. YoY growth: N/A. 5-year CAGR: N/A.
What is ANVS's long-term revenue growth rate?
Annovis Bio, Inc.'s 5-year revenue CAGR of N/A reflects the variable expansion pattern. Current YoY growth of N/A is near this long-term average.
How is ANVS's revenue distributed by segment?
ANVS reports revenue by product line and geographic region. Annual and quarterly breakdowns from 2017-2025 are available for download. Segment mix reveals concentration and diversification trends.